Skip to main content

Table 3 Differences in the amount/quantity of administered allogeneic blood products, coagulation factors and resuscitation fluids between the propensity score matched groups (LUKS: Cantonal Hospital Lucerne, USZ: University Hospital Zurich)

From: Comparison of two different coagulation algorithms on the use of allogenic blood products and coagulation factors in severely injured trauma patients: a retrospective, multicentre, observational study

 

USZ (n = 172)

LUKS (n = 172)

p-value

RBC (U)

0.5 (1.9)

1.5 (3.9)

< 0.001

FFP (U)

0.1 (0.6)

0.4 (2.2)

0.15

PLT (U)

0.1 (0.3)

0.1 (0.4)

0.32

FFP:RBC (ratio)

0.1 (0.3)

0.1 (0.3)

0.91

Fibrinogen (g)

1.1 (2.6)

1.5 (3.0)

0.05

PCC (IU)

124 (408)

454 (1011)

< 0.001

Factor XIII (IU)

116 (388)

51 (282)

0.04

Crystalloid (ml)

2130 (2642)

3944 (4064)

< 0.001

Starch (ml)

13 (94)

146 (319)

< 0.001

Gelatin (ml)

347 (722)

142 (392)

0.004

  1. Data reported as mean (SD). The p-value (Mann-Whitney test) was calculated between the groups. Level of significance 0.05
  2. FFP fresh frozen plasma, FXIII coagulation factor XIII, PCC 4 factor prothrombin complex concentrate, PLT platelet concentrate, RBC red blood cell concentrate